JP2016537396A5 - - Google Patents

Download PDF

Info

Publication number
JP2016537396A5
JP2016537396A5 JP2016533631A JP2016533631A JP2016537396A5 JP 2016537396 A5 JP2016537396 A5 JP 2016537396A5 JP 2016533631 A JP2016533631 A JP 2016533631A JP 2016533631 A JP2016533631 A JP 2016533631A JP 2016537396 A5 JP2016537396 A5 JP 2016537396A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
cycloalkyl
cycloalkylalkyl
haloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016533631A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016537396A (ja
JP6527513B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/066467 external-priority patent/WO2015077375A1/en
Publication of JP2016537396A publication Critical patent/JP2016537396A/ja
Publication of JP2016537396A5 publication Critical patent/JP2016537396A5/ja
Application granted granted Critical
Publication of JP6527513B2 publication Critical patent/JP6527513B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016533631A 2013-11-20 2014-11-19 Tamファミリーキナーゼ阻害剤としてのキナゾリン誘導体 Active JP6527513B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361906779P 2013-11-20 2013-11-20
US61/906,779 2013-11-20
PCT/US2014/066467 WO2015077375A1 (en) 2013-11-20 2014-11-19 Quinazoline derivatives as tam family kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2016537396A JP2016537396A (ja) 2016-12-01
JP2016537396A5 true JP2016537396A5 (cg-RX-API-DMAC7.html) 2017-12-28
JP6527513B2 JP6527513B2 (ja) 2019-06-05

Family

ID=53180111

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016533631A Active JP6527513B2 (ja) 2013-11-20 2014-11-19 Tamファミリーキナーゼ阻害剤としてのキナゾリン誘導体

Country Status (7)

Country Link
US (1) US9771333B2 (cg-RX-API-DMAC7.html)
EP (1) EP3071204B1 (cg-RX-API-DMAC7.html)
JP (1) JP6527513B2 (cg-RX-API-DMAC7.html)
CN (1) CN105916506B (cg-RX-API-DMAC7.html)
AU (1) AU2014353006B2 (cg-RX-API-DMAC7.html)
CA (1) CA2929188C (cg-RX-API-DMAC7.html)
WO (1) WO2015077375A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190112317A1 (en) 2015-10-05 2019-04-18 The Trustees Of Columbia University In The City Of New York Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies
BR112020014140A2 (pt) 2018-01-17 2020-12-01 Vertex Pharmaceuticals Incorporated inibidores de dna-pk
US12269804B2 (en) 2018-01-17 2025-04-08 Vertex Pharmaceuticals Incorporated Quinoxalinone compounds, compositions, methods, and kits for increasing genome editing efficiency
WO2019143678A1 (en) * 2018-01-17 2019-07-25 Vertex Pharmaceuticals Incorporated Dna-pk inhibitors
CN111269125A (zh) * 2018-12-05 2020-06-12 上海复星星泰医药科技有限公司 一种艾乐替尼中间体及其制备方法
CN114380770B (zh) * 2021-12-24 2022-12-09 山东艾孚特科技有限公司 利用固体超强酸催化的甲基巯基噻二唑的合成工艺

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971783A (en) * 1973-03-07 1976-07-27 Pfizer Inc. 4-Aminoquinazoline derivatives as cardiac stimulants
US5721237A (en) * 1991-05-10 1998-02-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
US5710158A (en) 1991-05-10 1998-01-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
ES2241324T3 (es) 1998-10-08 2005-10-16 Astrazeneca Ab Derivados de quinazolina.
UA73993C2 (uk) 2000-06-06 2005-10-17 Астразенека Аб Хіназолінові похідні для лікування пухлин та фармацевтична композиція
GB0126433D0 (en) 2001-11-03 2002-01-02 Astrazeneca Ab Compounds
RU2004116911A (ru) 2001-11-03 2005-11-10 Астразенека Аб (Se) Производные хиназолина в качестве противоопухолевых средств
GB0128108D0 (en) 2001-11-23 2002-01-16 Astrazeneca Ab Therapeutic use
WO2003055866A1 (en) 2001-12-21 2003-07-10 Bayer Pharmaceuticals Corporation Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
ATE446093T1 (de) 2001-12-24 2009-11-15 Astrazeneca Ab Substituierte chinazolin-derivate als aurora- kinase inhibitoren
CN1665808A (zh) 2002-05-06 2005-09-07 沃泰克斯药物股份有限公司 噻二唑或噁二唑及其作为jak蛋白激酶抑制剂的用途
US7279499B2 (en) 2003-04-21 2007-10-09 Eli Lilly And Company Substituted benzopyrans as selective estrogen receptor-beta agonists
US20090036474A1 (en) 2004-10-12 2009-02-05 Patrick Ple Quinazoline derivatives for use against cancer
GB0427917D0 (en) 2004-12-21 2005-01-26 Astrazeneca Ab Chemical compounds
JP2008542345A (ja) 2005-05-28 2008-11-27 アストラゼネカ アクチボラグ キナゾリン類及びオーロラキナーゼ阻害剤としてのその使用
CA2621503C (en) 2005-09-07 2014-05-20 Rigel Pharmaceuticals, Inc. Triazole derivatives useful as axl inhibitors
GB0601215D0 (en) 2006-01-21 2006-03-01 Astrazeneca Ab Chemical compounds
NZ546477A (en) 2006-04-07 2009-04-30 Auckland Uniservices Ltd 4-Alkylamino-2-(heterocyclic)quinazolines and their use in cancer therapy
US8097630B2 (en) 2006-10-10 2012-01-17 Rigel Pharmaceuticals, Inc. Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors
WO2008080134A2 (en) 2006-12-22 2008-07-03 Rigel Pharmaceuticals, Inc. 4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors
CA2710051C (en) 2006-12-29 2017-05-16 Rigel Pharmaceuticals, Inc. Substituted triazoles useful as axl inhibitors
RS53281B (sr) 2006-12-29 2014-08-29 Rigel Pharmaceuticals Inc. Policiklični heteroaril supstituisani triazoli koji su korisni kao axl inhibitori
ES2406930T3 (es) 2006-12-29 2013-06-10 Rigel Pharmaceuticals, Inc. Triazoles sustituidos con arilo bicíclico y heteroarilo bicíclico útiles como inhibidores de AXL
CN101622248B (zh) 2006-12-29 2013-04-17 里格尔制药公司 用作axl抑制剂的n3-杂芳基取代的三唑和n5-杂芳基取代的三唑
CA2710230C (en) 2006-12-29 2016-02-23 Rigel Pharmaceuticals, Inc. Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
PT2118074E (pt) * 2007-02-01 2014-03-20 Resverlogix Corp Compostos para a prevenção e tratamento de doenças cardiovasculares
AU2008240188A1 (en) 2007-04-13 2008-10-23 Supergen, Inc. Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
GB0713259D0 (en) 2007-07-09 2007-08-15 Astrazeneca Ab Pyrazine derivatives 954
WO2009024825A1 (en) 2007-08-21 2009-02-26 Astrazeneca Ab 2-pyrazinylbenzimidazole derivatives as receptor tyrosine kinase inhibitors
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
EP2215085B1 (en) 2007-10-25 2011-09-07 AstraZeneca AB Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders
CA2704052C (en) 2007-10-26 2015-04-21 Rigel Pharmaceuticals, Inc. Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
HRP20161522T1 (hr) 2008-01-18 2017-02-10 Natco Pharma Limited Derivati 6.7-dialkoksi kinazolina korisni za liječenje poremećaja povezanih s rakom
AU2009226136B2 (en) 2008-03-17 2013-08-15 Ambit Biosciences Corporation Quinazoline derivatives as RAF kinase modulators and methods of use thereof
JP5746015B2 (ja) 2008-04-16 2015-07-08 マックス プランク ゲゼルシャフト ツゥアー フェデルゥン デル ヴィッセンシャフテン エー フォー Axlキナーゼ阻害剤としてのキノリン誘導体
CA2730251C (en) 2008-07-09 2016-08-09 Rigel Pharmaceuticals, Inc. Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
CA2730231C (en) 2008-07-09 2016-10-18 Rigel Pharmaceuticals, Inc. Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
BRPI1007046B1 (pt) 2009-01-16 2019-07-16 Rigel Pharmaceuticals, Inc. Inibidores axl para uso em terapia de combinação para evitar, tratar ou controlar o câncer metastático.
SG172857A1 (en) 2009-02-09 2011-08-29 Supergen Inc Pyrrolopyrimidinyl axl kinase inhibitors
US20120129875A1 (en) 2009-05-29 2012-05-24 Syngenta Crop Protection, Llc Substituted quinazolines as fungicides
EP2311809A1 (en) 2009-10-16 2011-04-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Quinolinyloxyphenylsulfonamides
MX2012005155A (es) 2009-11-03 2012-08-31 Glaxosmithkline Llc Compuestos de quinazolina.
CN101747329A (zh) 2009-12-31 2010-06-23 四川大学 一类4-芳硫基喹唑啉衍生物及制备方法和医药用途
CA2796967C (en) 2010-05-04 2015-12-01 Pfizer Inc. Heterocyclic derivatives as alk inhibitors
EP2423208A1 (en) 2010-08-28 2012-02-29 Lead Discovery Center GmbH Pharmaceutically active compounds as Axl inhibitors
CN102382065B (zh) 2010-08-30 2014-05-28 山东轩竹医药科技有限公司 苯胺取代的喹唑啉衍生物
EP3628665B1 (en) 2011-04-01 2022-11-02 University of Utah Research Foundation Substituted n-phenylpyrimidin-2-amine analogs as inhibitors of the axl kinase
EA023521B1 (ru) * 2011-11-14 2016-06-30 Сефалон, Инк. ПРОИЗВОДНЫЕ УРАЦИЛА В КАЧЕСТВЕ ИНГИБИТОРОВ AXL И c-MET КИНАЗЫ
SG11201404505PA (en) 2012-01-31 2014-10-30 Daiichi Sankyo Co Ltd Pyridone derivative
WO2013162061A1 (ja) 2012-04-26 2013-10-31 第一三共株式会社 二環性ピリミジン化合物

Similar Documents

Publication Publication Date Title
JP2010514832A5 (cg-RX-API-DMAC7.html)
JP2015509535A5 (cg-RX-API-DMAC7.html)
EA202090553A1 (ru) Производные 3-(1-оксоизоиндолин-2-ил)пиперидин-2,6-диона и варианты их применения
JP2016519165A5 (cg-RX-API-DMAC7.html)
EA201992126A1 (ru) Ингибиторы jak, содержащие 4-членный гетероциклический амид
PH12019500395A1 (en) Amino-pyrrolopyrimidinone compounds and methods of use thereof
JP2020502092A5 (cg-RX-API-DMAC7.html)
JP2015537020A5 (cg-RX-API-DMAC7.html)
JP2015509534A5 (cg-RX-API-DMAC7.html)
JP2016503052A5 (cg-RX-API-DMAC7.html)
JP2016529319A5 (cg-RX-API-DMAC7.html)
JP2016540742A5 (cg-RX-API-DMAC7.html)
JP2017523997A5 (cg-RX-API-DMAC7.html)
JP2018502148A5 (cg-RX-API-DMAC7.html)
RU2017116196A (ru) 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1
EA201700077A1 (ru) Соединения аминопиримидинила в качестве ингибиторов jak
JP2012513416A5 (cg-RX-API-DMAC7.html)
JP2016516043A5 (cg-RX-API-DMAC7.html)
JP2017523152A5 (cg-RX-API-DMAC7.html)
EA201691136A1 (ru) Производное на основе 1,2-нафтохинона и способ его получения
CY1118107T1 (el) Παραγωγα ετεροαρυλιου ως διαμορφωτες αλφα7 nachr
JP2019535723A5 (cg-RX-API-DMAC7.html)
JP2016529315A5 (cg-RX-API-DMAC7.html)
JP2013542267A5 (cg-RX-API-DMAC7.html)
HK1201534A1 (en) Pharmaceutical compounds